Inventor · disambiguated record
Jonathan Henry Ellis
Also filed as: ELLIS JONATHAN · ELLIS JONATHAN H · ELLIS JONATHAN HENRY
21 granted patents·33 pending applications·116 citations·filing 1999–2018
94Inventor score
Files withGLAXO GROUP LTD15ASHMAN CLAIRE8ELLIS JONATHAN HENRY7BURBIDGE STEPHEN ANTHONY3CLEGG STEPHANIE JANE3
Top patents by PatentIndex Score
54 records- 0189US10703814B2Method of treatment with humanized anti-IL-18 antibodiesGLAXO GROUP LTD·Filed 2018·Granted Jul 7, 2020·2 cites·13 claims
- 0287US7807788B2Chimeric and humanised monoclonal antibodies against Interleukin-13GLAXO GROUP LTD·Filed 2005·Granted Oct 5, 2010·22 cites·21 claims
- 0386US7780964B2Immunoglobulins which bind NOGOGLAXO GROUP LTD·Filed 2005·Granted Aug 24, 2010·9 cites·18 claims
- 0486US7612183B2Humanised anti-mag antibody or functional fragment thereofGLAXO GROUP LTD·Filed 2003·Granted Nov 3, 2009·21 cites·15 claims
- 0585US8133978B2Humanised anti-interleukin-18 antibodyELLIS JONATHAN HENRY·Filed 2007·Granted Mar 13, 2012·7 cites·7 claims
- 0683US8362208B2ImmunoglobulinsGLAXO GROUP LTD·Filed 2006·Granted Jan 29, 2013·6 cites·2 claims
- 0781US8227576B2Antibodies against amyloid-β peptideBURBIDGE STEPHEN ANTHONY·Filed 2007·Granted Jul 24, 2012·7 cites·18 claims
- 0881US7858753B2ImmunoglobulinsGLAXO GROUP LTD·Filed 2005·Granted Dec 28, 2010·7 cites·23 claims
- 0977US8858943B2Antigen binding proteinsBURBIDGE STEPHEN ANTHONY·Filed 2008·Granted Oct 14, 2014·6 cites·10 claims
- 1075US8637018B2Humanized anti-IL-18 antibodiesELLIS JONATHAN HENRY·Filed 2011·Granted Jan 28, 2014·2 cites·7 claims
- 1175US8071731B2Humanised anti-MAG antibody or functional fragment thereofELLIS JONATHAN HENRY·Filed 2008·Granted Dec 6, 2011·2 cites·6 claims
- 1272US7351818B2Method to improve translation of polypeptides by using untranslated regions from heat-shock proteinsSMITHKLINE BEECHAM CORP·Filed 2005·Granted Apr 1, 2008·1 cites·1 claims
- 1371US8680245B2IL-13 binding proteinASHMAN CLAIRE·Filed 2010·Granted Mar 25, 2014·3 cites·79 claims
- 1471US8496932B2CompoundsCLEGG STEPHANIE JANE·Filed 2008·Granted Jul 30, 2013·3 cites·8 claims
- 1570US8921523B2Humanized anti-beta-amyloid antibodiesALARD PHILIPPE MARC LOUIS·Filed 2008·Granted Dec 30, 2014·4 cites·7 claims
- 1664US9499617B2Humanized anti-IL-18 antibodiesGLAXO GROUP LTD·Filed 2013·Granted Nov 22, 2016·0 cites·7 claims
- 1763US2007269451A1Nucleic Acid VaccinationGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 1861US7988964B2NOGO-a neutralising immunoglobulin for treatment of neurological diseasesGLAXO GROUP LTD·Filed 2004·Granted Aug 2, 2011·2 cites·12 claims
- 1957US2017029497A1ImmunoglobulinsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 2056US2009148905A1Antigen-binding constructsASHMAN CLAIRE·Filed 2008·Application pending·0 cites
- 2156US2011008345A1Antigen-binding constructsASHMAN CLAIRE·Filed 2008·Application pending·0 cites
- 2255US2014147435A1NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological DiseasesELLIS JONATHAN HENRY·Filed 2013·Application pending·0 cites
- 2352US8828384B2CompoundsGLAXOSMITHKLINE·Filed 2013·Granted Sep 9, 2014·0 cites·4 claims
- 2452US7034142B1Method to improve translation of polypeptides by using untranslated regions from heat-shock proteinsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Apr 25, 2006·0 cites·8 claims
- 2552US2009130126A1Dna expression vectorsSMITHKLINE BEECHAM CORP·Filed 2007·Application pending·0 cites
- 2651US7008623B1Antibodies to CD23, derivatives thereof, and their therapeutic usesGLAXO WELLCOME INC·Filed 1999·Granted Mar 7, 2006·12 cites·10 claims
- 2751US2011206686A1Il-23 antibodiesBEMBRIDGE GARY PETER·Filed 2008·Application pending·0 cites
- 2851US2009123479A1ImmunoglobulinsBEMBRIDGE GARY PETER·Filed 2008·Application pending·0 cites
- 2951US2005186209A1VaccineFiled 2005·Application pending·0 cites
- 3050US9193784B2AntibodiesBURBIDGE STEPHEN ANTHONY·Filed 2012·Granted Nov 24, 2015·0 cites·16 claims
- 3150US2003133909A1Nucleic acid vaccinationFiled 2000·Application pending·0 cites
- 3250US2006147477A1Immunogenic compositionsGLAXO GROUP LTD·Filed 2003·Application pending·0 cites
- 3350US2006251665A1VaccinesBURDEN MICHAEL N·Filed 2003·Application pending·0 cites
- 3449US2010047243A1Novel antibodies against igf-irBURDEN MICHAEL NEIL·Filed 2008·Application pending·0 cites
- 3549US2011054149A1NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological DiseasesELLIS JONATHAN HENRY·Filed 2010·Application pending·0 cites
- 3649US2003194391A1VaccineFiled 2002·Application pending·0 cites
- 3748US2011256132A1Myostatin binding proteinsASHMAN CLAIRE·Filed 2009·Application pending·0 cites
- 3848US2005032133A1Method of determining whether a patient afflicted with cancer can be treated by a therapeutic agent that targets the 17-1a antigenFiled 2002·Application pending·0 cites
- 3948US2013287781A1ImmunoglobulinsGLAXO GROUP LTD·Filed 2013·Application pending·0 cites
- 4048US2005158305A1Humanized antibodies to CD38WELLCOME FOUND·Filed 2004·Application pending·0 cites
- 4148US2011262430A1Novel antibodiesELLIS JONATHAN HENRY·Filed 2008·Application pending·0 cites
- 4246US2005260216A1VaccineASHMAN CLAIRE·Filed 2002·Application pending·0 cites
- 4345US2016024197A1Antibodies against amyloid-beta peptideGLAXO GROUP LTD·Filed 2015·Application pending·0 cites
- 4444US2002164788A1Humanized antibodies to CD38WELLCOME FOUND·Filed 2001·Application pending·0 cites
- 4543US2004082531A1Dna expression vectorsFiled 2001·Application pending·0 cites
- 4642US2016207993A1Antigen-binding constructsGLAXO GROUP LTD·Filed 2015·Application pending·0 cites
- 4742US2011105724A1Novel compoundsCLEGG STEPHANIE JANE·Filed 2008·Application pending·0 cites
- 4841US2011245470A1ImmunoglobulinsGLAXO GROUP LTD·Filed 2010·Application pending·0 cites
- 4940US2006147417A1Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic useASHMAN CLAIRE·Filed 2003·Application pending·0 cites
- 5039US2006104943A1Vaccine comprising il-13 and an adjuvantASHMAN CLAIRE·Filed 2003·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →